Janux Therapeutics Inc

NASDAQ:JANX 4:00:00 PM EDT

47.10

-1.11 (-2.30%)

5:22:15 PM EDT: $47.20 +0.10 (+0.21%)

Market Cap (Intraday)	2.43B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.66 Million
Adjusted EPS	-$0.34

See more estimates

10-Day MA	$47.73
50-Day MA	$37.81
200-Day MA	$16.87

See more pivots

Janux Therapeutics Inc Stock, NASDAQ:JANX

10955 Vista Sorrento Parkway, Suite 200, San Diego, California 92130

United States of America

Phone: +1.858.751.4493

Number of Employees: 64

http://www.januxrx.com

Description

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.